Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.
Clinical Benefit
| Insufficient |
The actual benefit of LERCAPRESS 10 mg/10 mg is insufficient in view of the available clinical data: this data is insufficient to assess its value for the management of hypertensive patients. |
| Substantial |
|
Clinical Added Value
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
TZ5w9x9xKL5jzyhe
